Objective: The objective of this study was to determine the clinical features and risk factors for hospital-associated pulmonary thromboembolism (HA-PTE) in Taizhou Hospital of Zhejiang Province. Methods: The clinical data of 513 pulmonary thromboembolism (PTE) patients who were admitted to Taizhou Hospital of Zhejiang Province in from January 1st, 2020, to December 31st, 2022, were retrospectively analyzed. The HA-PTE group and the community-associated PTE (CA-PTE) group were classified according to whether these disorders occurred during hospitalization or within a 90-day period of admission to the hospital (including inpatients with at least two days of hospitalization stay or a surgical procedure under or regional anesthesia). Differences in clinical features, risk factors and other indicators were also analyzed between the two groups. Results: A total of 513 patients with acute PTE were analyzed in the present study. Among them, 134 patients had HA-PTE, and 379 patients had CA-PTE. Patients in the HA-PTE group had less dyspnea or hemoptysis and more fever and chest pain. The all-cause mortality rate in the HA-PTE group was greater than that in the CA-PTE group, but it was not statistically significant. In comparison to community-acquired pulmonary thromboembolism (CA-PTE), long-term bed rest, active malignancy, lung infection, acute cerebral infarction, and fracture were observed as more prevalent risk factors in the hospital-acquired pulmonary thromboembolism (HA-PTE) group. Additionally, recent surgery (within one month post-operation) and central venous catheterization were identified as independent risk factors in the HA-PTE group. According to the subgroup analysis of the HA-PTE group, the all-cause mortality rate of patients who experienced HA-PTE in the hospital was lower than that of patients who experienced HA-PTE which in 90 days after admission (1.56% versus 2.85%, respectively); however, the difference was not statistically significant. Conclusion: More than half of the HA-PTE events were associated with recent hospitalization. HA-PTE and CA-PTE have different risk factors; when combined with different clinical symptoms, they have a higher incidence of HA-PTE occurring in the hospital. More attention should be given to inpatients to reduce the incidence of HA-PTE.
| Published in | American Journal of Life Sciences (Volume 12, Issue 5) |
| DOI | 10.11648/j.ajls.20241205.12 |
| Page(s) | 95-103 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Pulmonary Thromboembolism, Clinical Feature, Risk Factor, Hospitalization
| [1] | Tritschler T, Kraaijpoel N, Le Gal G, et al. Venous Thromboembolism: Advances in Diagnosis and Treatment. JAMA. 2018 Oct 16; 320(15): 1583-1594. |
| [2] | Chopard R, Albertsen IE, Piazza G. Diagnosis and Treatment of Lower Extremity Venous Thromboembolism: A Review. JAMA. 2020 Nov 3; 324(17): 1765-1776. |
| [3] | Arnold MJ. Thromboembolic Disease. Prim Care. 2024 Mar; 51(1): 65-82. |
| [4] | Wang KL, Yap ES, Goto S, Zhang S, Siu CW, Chiang CE. The diagnosis and treatment of venous thromboembolism in asian patients. Thromb J. 2018 Jan 18; 16: 4. |
| [5] | Zhang J, Hu X, Wang T, Xiao R, Zhu L, Ruiz M, Dupuis J, Hu Q. Extracellular vesicles in venous thromboembolism and pulmonary hypertension. J Nanobiotechnology. 2023 Nov 30; 21(1): 461. |
| [6] | Wenger N, Sebastian T, Engelberger RP, et al. Pulmonary embolism and deep vein thrombosis: Similar but different. Thromb Res. 2021 Oct; 206: 88-98. |
| [7] | Huang W, Goldberg RJ, Cohen AT, et al. Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009). Thromb Res. 2015 Jun; 135(6): 1100-6. |
| [8] | Heit JA, Crasan DJ, Ashrani AA, et al. Effect of a near-universal inpatient-based prophylax regimen on annual number of venous thromboembolism events in the US [J]. Blood, 2017, 130(2): 109-114. |
| [9] | Stubbs JM, Assareh H, Curnow J, et al. Variation in the incidence and timing of diagnosis of hospital-associated venous thromboembolism using links administrative data [J]. Intern Medical J, 2018, 48(9): 1137-1141. |
| [10] | Spencer FA, Lessard D, Emery C, et al. Venous thromboembolism in the outpatient setting in the outpatient setting. Arch Intern Med, 2007, 167(14): 1471-1475. |
| [11] | Terren T, Jason B. Diagnosis and Management of Pulmonary Embolism. Emerg Med Clin N Am 40(2022): 565–581. |
| [12] | Rogers MAM, Levine DA, Blumberg N, et al. Triggers for Hospitalization for Venous Thromboembolism. Circulation, 2012, 125(17): 2092-2141. |
| [13] | Smeeth L, Cook C, Thomas S, et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting [J]. LANCET, 2006, 367(9516): 1075-1079. |
| [14] | Johnnesan C, Flachs EM, Ebbehoj NE, et al. Sedentary work and risk of venous thromboembolism [J]. Scand J Work Env Hea, 2020, 46(1): 69-76. |
| [15] | Miele C, Mennitti C, Gentile A, et al. Thrombosis and Thrombotic Risk in Athletes. J Clin Med. 2024 Aug 19; 13(16): 4881. |
| [16] | Stein PD, Beemath A, Meyes FA, et al. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med, 2006, 119(1): 60- 68. |
| [17] | Leslom AN, Alrawiah ZMS, Al-Asmari AMA, et al. Prevalence of pulmonary thromboembolism in patients with nephrotic syndrome: a systematic review and meta-analysis [J]. J Family Med Prim Care, 28 February 2020; 9(2): 497-501. |
| [18] | Knudson MM, Moore EE, kornblith LZ, et al. Challenging Traditional Paradigms in Posttraumatic Pulmonary Thromboembolism [J]. JAMA Surg, February 1, 2022; 157(2): e216356. |
| [19] | Mi YH, Xu MY. Trauma-induced pulmonary thromboembolism: What's update? [J]. Chin J Traumatol, March 2022; 25(2): 67-76. |
| [20] | Perincek G, Hatipoglu ON, Tabakoglu E, et al. Relation of the frequency and mortality of pulmonary thromboembolism with meteorological parameters [J]. Acta Biomed, 08 October 2018; 89(3): 370-377. |
| [21] | Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe: The number of VTE events and associated morbidity and mortality [J]. Thromb Haemost, 2007, 98(4): 756-764. |
APA Style
Zheng, Y., Chunlong, W. (2024). Clinical Features and Risk Factors of 134 HA-PTE Patients. American Journal of Life Sciences, 12(5), 95-103. https://doi.org/10.11648/j.ajls.20241205.12
ACS Style
Zheng, Y.; Chunlong, W. Clinical Features and Risk Factors of 134 HA-PTE Patients. Am. J. Life Sci. 2024, 12(5), 95-103. doi: 10.11648/j.ajls.20241205.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajls.20241205.12,
author = {Yang Zheng and Wu Chunlong},
title = {Clinical Features and Risk Factors of 134 HA-PTE Patients
},
journal = {American Journal of Life Sciences},
volume = {12},
number = {5},
pages = {95-103},
doi = {10.11648/j.ajls.20241205.12},
url = {https://doi.org/10.11648/j.ajls.20241205.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajls.20241205.12},
abstract = {Objective: The objective of this study was to determine the clinical features and risk factors for hospital-associated pulmonary thromboembolism (HA-PTE) in Taizhou Hospital of Zhejiang Province. Methods: The clinical data of 513 pulmonary thromboembolism (PTE) patients who were admitted to Taizhou Hospital of Zhejiang Province in from January 1st, 2020, to December 31st, 2022, were retrospectively analyzed. The HA-PTE group and the community-associated PTE (CA-PTE) group were classified according to whether these disorders occurred during hospitalization or within a 90-day period of admission to the hospital (including inpatients with at least two days of hospitalization stay or a surgical procedure under or regional anesthesia). Differences in clinical features, risk factors and other indicators were also analyzed between the two groups. Results: A total of 513 patients with acute PTE were analyzed in the present study. Among them, 134 patients had HA-PTE, and 379 patients had CA-PTE. Patients in the HA-PTE group had less dyspnea or hemoptysis and more fever and chest pain. The all-cause mortality rate in the HA-PTE group was greater than that in the CA-PTE group, but it was not statistically significant. In comparison to community-acquired pulmonary thromboembolism (CA-PTE), long-term bed rest, active malignancy, lung infection, acute cerebral infarction, and fracture were observed as more prevalent risk factors in the hospital-acquired pulmonary thromboembolism (HA-PTE) group. Additionally, recent surgery (within one month post-operation) and central venous catheterization were identified as independent risk factors in the HA-PTE group. According to the subgroup analysis of the HA-PTE group, the all-cause mortality rate of patients who experienced HA-PTE in the hospital was lower than that of patients who experienced HA-PTE which in 90 days after admission (1.56% versus 2.85%, respectively); however, the difference was not statistically significant. Conclusion: More than half of the HA-PTE events were associated with recent hospitalization. HA-PTE and CA-PTE have different risk factors; when combined with different clinical symptoms, they have a higher incidence of HA-PTE occurring in the hospital. More attention should be given to inpatients to reduce the incidence of HA-PTE.
},
year = {2024}
}
TY - JOUR T1 - Clinical Features and Risk Factors of 134 HA-PTE Patients AU - Yang Zheng AU - Wu Chunlong Y1 - 2024/10/29 PY - 2024 N1 - https://doi.org/10.11648/j.ajls.20241205.12 DO - 10.11648/j.ajls.20241205.12 T2 - American Journal of Life Sciences JF - American Journal of Life Sciences JO - American Journal of Life Sciences SP - 95 EP - 103 PB - Science Publishing Group SN - 2328-5737 UR - https://doi.org/10.11648/j.ajls.20241205.12 AB - Objective: The objective of this study was to determine the clinical features and risk factors for hospital-associated pulmonary thromboembolism (HA-PTE) in Taizhou Hospital of Zhejiang Province. Methods: The clinical data of 513 pulmonary thromboembolism (PTE) patients who were admitted to Taizhou Hospital of Zhejiang Province in from January 1st, 2020, to December 31st, 2022, were retrospectively analyzed. The HA-PTE group and the community-associated PTE (CA-PTE) group were classified according to whether these disorders occurred during hospitalization or within a 90-day period of admission to the hospital (including inpatients with at least two days of hospitalization stay or a surgical procedure under or regional anesthesia). Differences in clinical features, risk factors and other indicators were also analyzed between the two groups. Results: A total of 513 patients with acute PTE were analyzed in the present study. Among them, 134 patients had HA-PTE, and 379 patients had CA-PTE. Patients in the HA-PTE group had less dyspnea or hemoptysis and more fever and chest pain. The all-cause mortality rate in the HA-PTE group was greater than that in the CA-PTE group, but it was not statistically significant. In comparison to community-acquired pulmonary thromboembolism (CA-PTE), long-term bed rest, active malignancy, lung infection, acute cerebral infarction, and fracture were observed as more prevalent risk factors in the hospital-acquired pulmonary thromboembolism (HA-PTE) group. Additionally, recent surgery (within one month post-operation) and central venous catheterization were identified as independent risk factors in the HA-PTE group. According to the subgroup analysis of the HA-PTE group, the all-cause mortality rate of patients who experienced HA-PTE in the hospital was lower than that of patients who experienced HA-PTE which in 90 days after admission (1.56% versus 2.85%, respectively); however, the difference was not statistically significant. Conclusion: More than half of the HA-PTE events were associated with recent hospitalization. HA-PTE and CA-PTE have different risk factors; when combined with different clinical symptoms, they have a higher incidence of HA-PTE occurring in the hospital. More attention should be given to inpatients to reduce the incidence of HA-PTE. VL - 12 IS - 5 ER -
Quality Improvement Department of Taizhou Hospital of Zhejiang Province, Taizhou Enze Medical Center Group, Affiliated to Wenzhou Medical University, Linhai, China
Quality Improvement Department of Taizhou Hospital of Zhejiang Province, Taizhou Enze Medical Center Group, Affiliated to Wenzhou Medical University, Linhai, China
